Concepedia
Statistics
Publications
14
Citations
982
H-Index
13
Active since
2017
Affiliations
Baylor College of Medicine(Current)
Arrowhead Pharmaceuticals (United States)
Royal Prince Alfred Hospital
Université de Montréal
Auckland Institute of Studies
Ting Chang is an author at Baylor College of Medicine specializing in medicine, pharmacology, and pharmacotherapy.
Publications per year
2017–2024
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
Robert S. Rosenson, Daniel Gaudet, Robert A. Hegele et al. · New England Journal of Medicine · 2024 · 195 citations
Medicine, Pharmacology, Pharmacotherapy +12
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad et al. · New England Journal of Medicine · 2024 · 191 citations
Medicine, Molecular Medicine, Pharmacology +17
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis
Massimo Puoti, Graham R. Foster, Stanley Wang et al. · Journal of Hepatology · 2018 · 159 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Fazirsiran for Liver Disease Associated with Alpha <sub>1</sub> -Antitrypsin Deficiency
Pavel Strnad, Mattias Mandorfer, Gourab Choudhury et al. · New England Journal of Medicine · 2022 · 110 citations · Full text
Medicine, Molecular Biology, Molecular Medicine +14
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
Gerald F. Watts, Christian Schwabe, Russell L. Scott et al. · Nature Medicine · 2023 · 95 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 14